Cargando…
Transcriptome profiling of Ewing sarcomas – treatment resistance pathways and IGF‐dependency
Ewing sarcomas (ESs) are aggressive sarcomas driven by EWS fusion genes. We sought to investigate whether whole‐transcriptome sequencing (RNA‐seq) could be used to detect patterns associated with chemotherapy response or tumor progression after first‐line treatment. Transcriptome sequencing (RNA‐seq...
Autores principales: | Chen, Yi, Hesla, Asle C., Lin, Yingbo, Ghaderi, Mehran, Liu, Mingzhi, Yang, Chen, Zhang, Yifan, Tsagkozis, Panagiotis, Larsson, Olle, Haglund, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191197/ https://www.ncbi.nlm.nih.gov/pubmed/32115849 http://dx.doi.org/10.1002/1878-0261.12655 |
Ejemplares similares
-
Current Status of Management and Outcome for Patients with Ewing Sarcoma
por: Hesla, Asle Charles, et al.
Publicado: (2021) -
TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma
por: Zhang, Yifan, et al.
Publicado: (2021) -
Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study
por: Hesla, Asle Charles, et al.
Publicado: (2020) -
Identification of an RNA-Binding-Protein-Based Prognostic Model for Ewing Sarcoma
por: Chen, Yi, et al.
Publicado: (2021) -
An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma
por: Tsagozis, Panagiotis, et al.
Publicado: (2019)